OAK BROOK, Ill.--(BUSINESS WIRE)--Bio-Bridge Science, Inc. (OTCBB:BGES), a biotechnology company engaged in the commercial development of vaccines for the prevention and treatment of human infectious diseases, announced the appointment of Dr. Mitchell Kronenberg to the Scientific Advisory Board of the Company. Dr. Kronenberg is an internationally recognized leading expert on NKT cells and mucosal immunology. He has over 230 highly cited publications, is currently on the Finance Committee of the American Association of Immunologists and serves as a Deputy Editor for the Journal of Immunology. Dr. Kronenberg was named a Roy and Robert Kroc Distinguished Visiting Professor of Immunology and Medicine by the University of California, Davis in 2000, and was a Borroughs Wellcome Fund Visiting Professor at Harvard University in 2002.
